Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Clinical, genetic, and pathologic characterization of FKRP Mexican founder mutation c.1387A>G.

Lee AJ, Jones KA, Butterfield RJ, Cox MO, Konersman CG, Grosmann C, Abdenur JE, Boyer M, Beson B, Wang C, Dowling JJ, Gibbons MA, Ballard A, Janas JS, Leshner RT, Donkervoort S, B├Ânnemann CG, Malicki DM, Weiss RB, Moore SA, Mathews KD.

Neurol Genet. 2019 Mar 1;5(2):e315. doi: 10.1212/NXG.0000000000000315. eCollection 2019 Apr.


TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of ╬▒-dystroglycan and muscular dystrophy.

Larson AA, Baker PR 2nd, Milev MP, Press CA, Sokol RJ, Cox MO, Lekostaj JK, Stence AA, Bossler AD, Mueller JM, Prematilake K, Tadjo TF, Williams CA, Sacher M, Moore SA.

Skelet Muscle. 2018 May 31;8(1):17. doi: 10.1186/s13395-018-0163-0.


GMPPB-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation.

Jensen BS, Willer T, Saade DN, Cox MO, Mozaffar T, Scavina M, Stefans VA, Winder TL, Campbell KP, Moore SA, Mathews KD.

Hum Mutat. 2015 Dec;36(12):1159-63. doi: 10.1002/humu.22898. Epub 2015 Sep 23.


Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27.

Tsuda T, Fitzgerald K, Scavena M, Gidding S, Cox MO, Marks H, Flanigan KM, Moore SA.

J Hum Genet. 2015 Mar;60(3):151-5. doi: 10.1038/jhg.2014.112. Epub 2014 Dec 24.


Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies.

Davidson AE, Siddiqui FM, Lopez MA, Lunt P, Carlson HA, Moore BE, Love S, Born DE, Roper H, Majumdar A, Jayadev S, Underhill HR, Smith CO, von der Hagen M, Hubner A, Jardine P, Merrison A, Curtis E, Cullup T, Jungbluth H, Cox MO, Winder TL, Abdel Salam H, Li JZ, Moore SA, Dowling JJ.

Brain. 2013 Feb;136(Pt 2):508-21. doi: 10.1093/brain/aws344.


The issues and challenges of orofacial pain in the elderly.

Cox MO.

Spec Care Dentist. 2000 Nov-Dec;20(6):245-9. Review.


A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.

Summers MA, O'Dorisio MS, Cox MO, Lara-Marquez M, Goetzl EJ.

J Pharmacol Exp Ther. 2003 Aug;306(2):638-45. Epub 2003 May 15.


Oral leukocytes and gingivitis in the primary dentition.

Cox MO, Crawford JJ, Lundblad RL, McFall WT Jr.

J Periodontal Res. 1974;9(1):23-8. No abstract available.


Supplemental Content

Support Center